8OHdG Is Not a Biomarker for Huntington Disease State or Progression

Neurology - United States
doi 10.1212/wnl.0b013e318293e1a1
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Body Weight Is a Robust Predictor of Clinical Progression in Huntington Disease

Annals of Neurology
Neurology
2017English

MicroRNA-150 Is a Potential Biomarker of HIV/AIDS Disease Progression and Therapy

PLoS ONE
Multidisciplinary
2014English

Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?

JRSM Cardiovascular Disease
2019English

Author Correction: Myeloperoxidase Is Not a Good Biomarker for Preeclampsia Prediction

Scientific Reports
Multidisciplinary
2018English

Saliva/Pathogen Biomarker Signatures and Periodontal Disease Progression

Journal of Dental Research
Dentistry
2011English

ApoE Genotyping as a Progression-Rate Biomarker in Phase II Disease-Modification Trials for Alzheimer's Disease

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2009English

Is It or Is It Not a Pathogenic Mutation? Is It or Is It Not the Podocyte?

Journal of Nephropathology
Nephrology
2012English

Urinary Angiostatin: A Novel Biomarker of Kidney Disease Associated With Disease Severity and Progression

BMC Nephrology
Nephrology
2019English

A Cloned DNA Segment From the Telomeric Region of Human Chromosome 4p Is Not Detectably Rearranged in Huntington Disease Patients.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy